文献速递产科母胎医学

低剂量阿司匹林预防复发性自发性早产:按胎盘母体血管灌注不良分层的随机试验二次分析

Low-Dose Aspirin in the Prevention of Recurrent Spontaneous Preterm Birth Stratified by Placental Maternal Vascular Malperfusion: Secondary Analysis of a Randomized Trial.
PubMed 文献 · BJOG · 2026-10-23

该研究为APRIL试验的二次分析,纳入有自发性早产史且可获得既往胎盘组织学报告的妇女,按Amsterdam标准判定母体血管灌注不良(MVM)。结果显示,在MVM阳性亚组中,阿司匹林组复发性早产率显著低于安慰剂组(4.2% vs 45.0%,RR 0.09,95%CI 0.01-0.43,p=0.02);MVM阴性组无显著差异。

要点

  • 有自发性早产史且胎盘MVM阳性者,低剂量阿司匹林与复发性早产率降低相关。
  • MVM阳性亚组中阿司匹林组复发性早产4.2%,安慰剂组45.0%,RR 0.09(95%CI 0.01-0.43)。
  • MVM阴性亚组阿司匹林组复发性早产29.3%,安慰剂组17.2%,RR 1.70(95%CI 0.87-3.56,p=0.13)。

核心结论

  • 在有自发性早产史且既往胎盘存在MVM征象的妇女中,后续妊娠使用低剂量阿司匹林与复发性早产率降低相关。

研究设计与样本

  • APRIL研究的二次分析,该研究在荷兰34个中心评估低剂量阿司匹林与安慰剂预防自发性早产后复发性早产的效果。
  • 纳入有自发性早产史且可获得既往胎盘组织学报告的参与者,按Amsterdam标准将胎盘组织学报告分类为MVM存在与否。

主要发现

  • 既往自发性早产的胎盘组织学报告可得于41.3%(160/387)的参与者,其中27.5%(44/160)存在MVM。
  • MVM阳性参与者中,阿司匹林组复发性早产4.2%(1/24),安慰剂组45.0%(9/20),RR 0.09(95%CI 0.01-0.43,p=0.02)。
  • MVM阴性参与者中,阿司匹林组复发性早产29.3%(17/58),安慰剂组17.2%(10/58),RR 1.70(95%CI 0.87-3.56,p=0.13)。

临床怎么用

  • 对于有自发性早产史且既往胎盘组织学提示MVM的孕妇,可考虑使用低剂量阿司匹林以降低复发性早产风险。
  • MVM阴性者使用低剂量阿司匹林未显示复发性早产率降低,需个体化评估。

局限性

  • 本研究为二次分析,仅41.3%的参与者有既往胎盘组织学报告,MVM阳性亚组样本量小。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the effectiveness of low-dose aspirin in the prevention of recurrent preterm birth (PTB) in women with signs of maternal vascular malperfusion (MVM) in the placenta of the previous spontaneous PTB. DESIGN: Secondary analysis of the APRIL study. SETTING: The APRIL study, conducted in 34 centres in the Netherlands, evaluated low-dose aspirin versus placebo in the prevention of recurrent PTB after spontaneous PTB. POPULATION: Women with a history of spontaneous PTB participating in the APRIL study, with available placenta histology reports from the previous spontaneous PTB. METHODS: Placental histology reports were retrieved from participating centres and categorized for presence of MVM as defined by the Amsterdam criteria. MAIN OUTCOME MEASURES: Recurrent PTB. RESULTS: Placental histology reports of the previous spontaneous PTB were available for 41.3% (160/387) of participants, and MVM was present in 27.5% (44/160). In participants with MVM, recurrent PTB occurred in 4.2% (1/24) of the aspirin group, versus in 45.0% (9/20) in the placebo group (Relative Risk (RR) 0.09; 95% Confidence Interval (CI) 0.01-0.43; p = 0.02). In participants without MVM, PTB occurred in 29.3% (17/58) in the aspirin group compared to 17.2% (10/58) in the placebo group (RR 1.70; 95% CI 0.87-3.56; p = 0.13). CONCLUSION: In women with a history of spontaneous PTB and signs of MVM in the placenta, a vascular-mediated subgroup, the use of low-dose aspirin in a subsequent pregnancy was associated with a lower rate of recurrent PTB.

来源:BJOG,查看原文。版权归原作者所有。

引用

  1. Meliëzer JAL, Landman AJEMC, Gieskes AA, et al. Low-Dose Aspirin in the Prevention of Recurrent Spontaneous Preterm Birth Stratified by Placental Maternal Vascular Malperfusion: Secondary Analysis of a Randomized Trial. BJOG. 2026. PMID: 42919680. doi:10.1111/1471-0528.70350

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。